Most recently, increasing attention has been turned to the application of stenting techniques in the treatment of prostatic obstruction.
Although the use of stents is common in other peripheral vessels, the application of stents in the infrapopliteal bed remains highly controversial.
While application criteria of stent graft placement are yet to be established, the arterial pseudoaneurysm attributable to POPF should be treated carefully.
Despite improvements in the results and techniques of catheter-based revascularization, few studies have evaluated the clinical results of the application of new stent designs.
In addition, it also plays an important role in restenosis in the vascular system after application of a stent.
Application of a stent into the parent artery alters the intra-aneurysmal flow pattern that facilitates thrombosis and reduction of coil compaction in the region of inflow zone and prevents subsequent regrowth of aneurysm [ 7].
Compared with the use of 1 single stent/artery, serial application of two stents leads to a more excessive but not significantly different neointimal proliferation (p > 0.05).
These results suggest potentially promising performance of S-SIBS-coated stent in human clinical applications of coronary stenting.
We report the successful application of a homemade stent graft, which had been designed according to a preliminary angiographic assessment, to simultaneously treat left pulmonary artery stenosis and residual shunt, without reoperative sternotomy, long after Fontan completion.
The application of EPC in stenting technology during vascular revascularization is the Genous EPC stent (OrbusNeich, Wanchai, Hong Kong), which is a stainless-steel stent coated with immobilized human anti-CD34 monoclonal antibodies that allow the stent surface to "capture" EPCs in the blood to accelerate endothelialization of the stent strut.
